JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB88254

Anti-VPS33A antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Mouse Polyclonal VPS33A antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human Vacuolar protein sorting-associated protein 33A.

View Alternative Names

Vacuolar protein sorting-associated protein 33A, hVPS33A, VPS33A

3 Images
Western blot - Anti-VPS33A antibody (AB88254)
  • WB

Unknown

Western blot - Anti-VPS33A antibody (AB88254)

All lanes:

Western blot - Anti-VPS33A antibody (ab88254) at 1 µg/mL

All lanes:

Human pancreas tissue lysate at 50 µg

Predicted band size: 68 kDa

false

Western blot - Anti-VPS33A antibody (AB88254)
  • WB

Unknown

Western blot - Anti-VPS33A antibody (AB88254)

All lanes:

Western blot - Anti-VPS33A antibody (ab88254) at 1 µg/mL

All lanes:

HepG2 cell lysate at 50 µg

Predicted band size: 68 kDa

false

Western blot - Anti-VPS33A antibody (AB88254)
  • WB

Unknown

Western blot - Anti-VPS33A antibody (AB88254)

All lanes:

Western blot - Anti-VPS33A antibody (ab88254) at 1 µg/mL

Lane 1:

VPS33A transfected 293T cell line at 25 µg

Lane 2:

Non-transfected 293T cell line at 25 µg

Predicted band size: 68 kDa

Observed band size: 66 kDa

false

Key facts

Host species

Mouse

Clonality

Polyclonal

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human Vacuolar protein sorting-associated protein 33A.

Q96AX1

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act as a core component of the putative HOPS and CORVET endosomal tethering complexes which are proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations (PubMed : 23351085, PubMed : 24554770, PubMed : 25266290, PubMed : 25783203). Required for fusion of endosomes and autophagosomes with lysosomes; the function is dependent on its association with VPS16 but not VIPAS39 (PubMed : 25783203). The function in autophagosome-lysosome fusion implicates STX17 but not UVRAG (PubMed : 24554770).
See full target information Vacuolar protein sorting-associated protein 33A

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Archives of pharmacal research 45:475-493 PubMed35767208

2022

Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Noha F Abdelkader,Marawan A Elbaset,Passant E Moustafa,Sherehan M Ibrahim
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com